{"id":5225,"date":"2011-02-22T00:00:35","date_gmt":"2011-02-22T05:00:35","guid":{"rendered":"http:\/\/insidesurgery.com\/?p=5225"},"modified":"2014-02-06T09:37:16","modified_gmt":"2014-02-06T14:37:16","slug":"cardioselective-beta-blockers","status":"publish","type":"post","link":"https:\/\/insidesurgery.com\/2011\/02\/cardioselective-beta-blockers\/","title":{"rendered":"Cardioselective Beta Blockers"},"content":{"rendered":"
The following cardioselective beta blockers are considered to largely cardioselective with effect largely on beta 1 receptors (vasodilation and slowing heart rate) and only minimal effect if any on beta 2 receptors (causing pulmonary constriction)<\/p>\n
A<\/strong>tenolol
\nM<\/strong>etoprolol
\nE<\/strong>smolol
\nB<\/strong>isoprolol
\nB<\/strong>etaxolol
\nA<\/strong>cebutolol<\/p>\n